NicOx is a product-driven biopharmaceutical company dedicated to the development and future commercialization of investigational nitric oxide-donating drugs to meet unmet medical needs. NicOx is applying its proprietary nitric oxide-donating technology to develop an internal portfolio of New Chemical Entities (NCEs) in the therapeutic areas of inflammation and cardio-metabolic disease.
